Id1, Spp1 and Pak3 are biomarkers of Smad4 and TGF-β1 dependency in conditional intestinal adenoma, organoids and colorectal cancer.

M Surakhy, J Matheson, D Barnes, E Carter, J Hughes… - bioRxiv, 2024 - biorxiv.org
The evolutionarily conserved TGF-β signalling pathway suppresses cell growth, yet loss of
function results in cancer phenotypes. Here, we evaluate loss of the TGF-β pathway signal …

SMAD4 suppresses WNT-driven dedifferentiation and oncogenesis in the differentiated gut epithelium

AO Perekatt, PP Shah, S Cheung, N Jariwala, A Wu… - Cancer research, 2018 - AACR
The cell of origin of colon cancer is typically thought to be the resident somatic stem cells,
which are immortal and escape the continual cellular turnover characteristic of the intestinal …

[HTML][HTML] SMAD4 mutations do not preclude epithelial–mesenchymal transition in colorectal cancer

P Frey, A Devisme, K Rose, M Schrempp, V Freihen… - Oncogene, 2022 - nature.com
Transforming growth factor beta (TGFβ) superfamily signaling is a prime inducer of epithelial-
mesenchymal transitions (EMT) that foster cancer cell invasion and metastasis, a major …

[PDF][PDF] The adenoma-carcinoma sequence in colorectal Cancer: scratching the surface

P Alberici - 2007 - repub.eur.nl
Colorectal cancer represents not only the second leading cause of cancer-related death in
Western world. The sequence of events that describes colorectal cancer development, the …

Role of TGF-β/SMAD4/c-MYC-regulated NLE1 in tumor growth and liver metastasis of colorectal cancer

L Loevenich - 2023 - edoc.ub.uni-muenchen.de
TGF-β signaling plays an essential role in colorectal cancer (CRC) progression. Patients
frequently suffer from mutations in the TGFBR2 gene or deletions of SMAD4. These …

Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis

S Miyamoto, T Fukui, S Horitani, Y Tanimura… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: This study analysed threonine-phosphorylated Smad2/3 (pSmad2/3L-Thr)
expression and investigated whether pSmad2/3L-Thr is related to the transition from human …

Smad4 haploinsufficiency in mouse models for intestinal cancer

P Alberici, S Jagmohan-Changur, E De Pater… - Oncogene, 2006 - nature.com
Abstract The Smad4+/E6sad mouse carries a null mutation in the endogenous Smad4 gene
resulting in serrated adenomas and mixed polyposis of the upper gastrointestinal (GI) tract …

SMAD4 loss is associated with poor prognosis in Middle Eastern colorectal cancer

M Ahmed, AK Siraj, T Masoodi, R Bu, F Al-Dayel… - Cancer Research, 2017 - AACR
Background: Colorectal cancer (CRC) is major cause of morbidity and mortality in cancer
patients worldwide and it ranks as the most common cancer in males and the third most …

Multiomics of colorectal cancer organoids reveals putative mediators of cancer progression resulting from SMAD4 inactivation

JJ Dijkstra, HK Neikes, S Rezaeifard, X Ma… - Journal of Proteome …, 2022 - ACS Publications
The development of metastasis severely reduces the life expectancy of patients with
colorectal cancer (CRC). Although loss of SMAD4 is a key event in CRC progression, the …

Colorectal Cancer-Associated Smad4 R361 Hotspot Mutations Boost Wnt/β-Catenin Signaling through Enhanced Smad4–LEF1 Binding

CB Lanauze, P Sehgal, K Hayer, M Torres-Diz… - Molecular Cancer …, 2021 - AACR
Abstract About 10% to 30% of patients with colorectal cancer harbor either loss of or
missense mutations in SMAD4, a critical component of the TGFβ signaling pathway. The …